Rashed Reyadh Khazaal Chairman & Managing Director Kuwait Saudi Pharmaceutical Industries Company Joined Mezzan in Sept 2017 and appointed as Chairman and MD in KSP in Sept 2019. Over 15 years of experience in the Gulf’s healthcare sector. Mr. Khazal hold a Doctorate of Business Administration in Action learning from University of Liverpool, an MBA in Strategy and General Management from Maastricht School of Management. Graduated from University of Portsmouth in UK with a Degree in Master of Pharmacy, MPHARM. About Dr. Rashed Reyadh Khazaal Firm Profile We are a fully-integrated pharmaceutical company, with development, manufacturing and sales capabilities, serving a regional population of 100 million patients and are expanding to reach even more patients globally. With over 15 years track record of successful manufacturing and distribution of pharmaceutical products for local and regional customers, KSP is undergoing the next stage of its impressive journey. Following the recent acquisition of a majority stake in KSP by a large local conglomerate, KSP now has the financial backing and investor support to continue its growth. This investment is both in manufacturing lines, manufacturing buildings, acquisitions and partnerships to develop the product and portfolio range, from its current level of over 120 products, to enable the provision of a wider and broader range of high-quality medicines, throughout the Middle-East and further afield. KSP has implemented a unique business model based on creating a highly collaborative partnership that facilitates a win-win outcome in which both KSP and distributors are equally committed to each other’s success. A collaborative Supplier-Distributor partnership means that KSP objective is to ensure the success of all distributors, with high retention rate & long lasting relationship. www.kspico.com Dr. CEO Today Middle East Awards 2023 - KUWAIT - - 79 -
RkJQdWJsaXNoZXIy Mjk3Mzkz